Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cts (CTS) Research & Development (2016 - 2026)

Cts filings provide 17 years of Research & Development readings, the most recent being $6.6 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 7.17% to $6.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.7 million, a 11.91% increase, with the full-year FY2025 number at $25.3 million, up 8.04% from a year prior.
  • Research & Development hit $6.6 million in Q1 2026 for Cts, up from $5.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6.9 million in Q3 2025 to a low of $5.0 million in Q3 2024.
  • Median Research & Development over the past 5 years was $6.2 million (2022), compared with a mean of $6.1 million.
  • Biggest five-year swings in Research & Development: dropped 20.41% in 2024 and later surged 37.17% in 2025.
  • Cts' Research & Development stood at $5.4 million in 2022, then decreased by 2.13% to $5.3 million in 2023, then rose by 7.18% to $5.7 million in 2024, then rose by 3.21% to $5.9 million in 2025, then grew by 13.36% to $6.6 million in 2026.
  • The last three reported values for Research & Development were $6.6 million (Q1 2026), $5.9 million (Q4 2025), and $6.9 million (Q3 2025) per Business Quant data.